{"id":23385,"date":"2024-03-25T15:30:00","date_gmt":"2024-03-25T14:30:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=23385"},"modified":"2024-03-25T14:36:49","modified_gmt":"2024-03-25T13:36:49","slug":"volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/","title":{"rendered":"Volumina Medical raises USD 21 million to advance regenerative medicine"},"content":{"rendered":"\n<p>Founded as a spin-off from the EPFL in 2018, <a href=\"https:\/\/www.volumina-medical.ch\/\">Volumina Medical<\/a> specializes in regenerative medicine for dermatology and plastic surgery. The company&#8217;s cutting-edge solution, Adipearl, is an innovative injectable dermal filler designed to regenerate soft tissues, addressing a critical need for millions worldwide seeking reconstruction or aesthetic enhancements post-surgery or due to disease.<\/p>\n\n\n\n<p>The recent funding milestone will be instrumental in expanding clinical trials involving Adipearl, spearheaded by leading Key Opinion Leaders (KOLs) in Europe. These trials are crucial for accumulating extensive clinical evidence necessary to navigate Adipearl towards commercialization, promising to offer natural and lasting solutions to enhance patient health and well-being.<\/p>\n\n\n\n<p>Reflecting on the initial patient responses to Adipearl, CEO and Co-Founder Am\u00e9lie B\u00e9duer said: \u201cI will never forget the intensity of the smiles on the face of the first patients that were treated with Adipearl. Together with this funding round, it is providing us a lot of confidence and an extremely high energy to continue to develop Volumina Medical and offer our solution to millions of patients.\u201d<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Answering a true need of patients<\/h4>\n\n\n\n<p>In the company\u2019s press release, the enthusiasm is echoed by Silvia Scherer, Chairwoman of the board, who noted the market&#8217;s growing interest in Adipearl and its promising outcomes: \u201cThis new funding round provides a strong commitment and allows the Volumina team to continue its steady progress and answer a true need of patients.\u201d<\/p>\n\n\n\n<p>Volumina Medical&#8217;s journey is backed by a consortium of initial financiers including <a href=\"https:\/\/blueocean-ventures.com\/\">BlueOcean Ventures<\/a>, <a href=\"https:\/\/www.zkb.ch\/\">ZKB<\/a>, <a href=\"https:\/\/skyviewslifescience.com\/\">Skyviews Life Sciences<\/a>, <a href=\"https:\/\/cliniquelaprairiemedical.com\/fr\">Clinique La Prairie<\/a>, and various private investors. The company has also garnered support from multiple programs and institutions like <a href=\"https:\/\/www.innosuisse.ch\/inno\/en\/home.html\">Innosuisse<\/a>, <a href=\"https:\/\/www.venturekick.ch\/\">Venture Kick<\/a>, <a href=\"https:\/\/www.venturelab.swiss\/\">Venturelab<\/a>, and the European Institute of Innovation and Technology (<a href=\"https:\/\/eithealth.eu\/\">EIT Health<\/a>), marking its remarkable ascent in the regenerative medicine arena.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.<\/p>\n","protected":false},"author":6,"featured_media":23386,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[957,894,890,963,926,902],"class_list":["post-23385","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-cosmetics","tag-financing","tag-healthcare","tag-medical-devices","tag-medtech","tag-personalized-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Volumina Medical raises USD 21 million for its Adipearl solution<\/title>\n<meta name=\"description\" content=\"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volumina Medical raises USD 21 million for its Adipearl solution\" \/>\n<meta property=\"og:description\" content=\"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-25T14:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Volumina Medical raises USD 21 million to advance regenerative medicine\",\"datePublished\":\"2024-03-25T14:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\"},\"wordCount\":303,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg\",\"keywords\":[\"Cosmetics\",\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\",\"url\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\",\"name\":\"Volumina Medical raises USD 21 million for its Adipearl solution\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg\",\"datePublished\":\"2024-03-25T14:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"This financial infusion is set to bolster the clinical advancement of Volumina Medical\u2019s injectable dermal filler, Adipearl. | \u00a9 Volumina Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volumina Medical raises USD 21 million to advance regenerative medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volumina Medical raises USD 21 million for its Adipearl solution","description":"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/","og_locale":"en_US","og_type":"article","og_title":"Volumina Medical raises USD 21 million for its Adipearl solution","og_description":"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.","og_url":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-03-25T14:30:00+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Volumina Medical raises USD 21 million to advance regenerative medicine","datePublished":"2024-03-25T14:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/"},"wordCount":303,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg","keywords":["Cosmetics","Financing","Healthcare","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/","url":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/","name":"Volumina Medical raises USD 21 million for its Adipearl solution","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg","datePublished":"2024-03-25T14:30:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Volumina Medical, a pioneering medtech based at the Biop\u00f4le in Epalinges, has successfully secured USD 21 million in Series A funding.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Volumina-Medical-1180x811-1.jpg","width":1180,"height":811,"caption":"This financial infusion is set to bolster the clinical advancement of Volumina Medical\u2019s injectable dermal filler, Adipearl. | \u00a9 Volumina Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/volumina-medical-raises-usd-21-million-to-advance-regenerative-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Volumina Medical raises USD 21 million to advance regenerative medicine"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/23385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=23385"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/23385\/revisions"}],"predecessor-version":[{"id":23389,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/23385\/revisions\/23389"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/23386"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=23385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=23385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=23385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}